Related Experiment Video
Updated: Apr 25, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Mitochondria: roles in pulmonary hypertension
Véronique Freund-Michel1, Nafiisha Khoyrattee1, Jean-Pierre Savineau1
1Univ. Bordeaux, Centre de recherche Cardio-Thoracique de Bordeaux, U1045, F-33000, Bordeaux, France; INSERM, Centre de recherche Cardio-Thoracique de Bordeaux, U1045, F-33000 Bordeaux, France.
Mitochondria, crucial for cell energy, are altered in pulmonary hypertension (PH). A shift from oxidative phosphorylation to glycolysis in mitochondria may drive PH progression, offering new therapeutic targets for this condition.
Area of Science:
- Cell Biology
- Cardiovascular Physiology
- Mitochondrial Medicine
Background:
- Mitochondria are vital for cellular ATP production and oxygen sensing in the pulmonary vasculature.
- They regulate physiological processes like hypoxic pulmonary vasoconstriction.
- Mitochondria also play a significant role in the pathophysiology of pulmonary hypertension (PH).
Purpose of the Study:
- To investigate the role of mitochondrial alterations in the pathogenesis of pulmonary hypertension.
- To explore the metabolic shift from oxidative phosphorylation to glycolysis in PH.
- To identify potential therapeutic strategies targeting mitochondrial dysfunction in PH.
Main Methods:
- Analysis of mitochondrial function in pulmonary arteries and right ventricles of PH models.
- Assessment of energy production pathways, focusing on oxidative phosphorylation and glycolysis.
- Comparative studies with metabolic alterations observed in cancer cells.
Main Results:
- Mitochondrial alterations, including a shift to glycolysis, are evident in pulmonary arteries and right ventricles in PH.
- This metabolic reprogramming mirrors changes seen in cancer cells.
- The observed mitochondrial dysfunction is linked to the progression of PH.
Conclusions:
- Mitochondrial metabolic reprogramming, specifically increased glycolysis, is a key feature in pulmonary hypertension.
- These findings suggest that targeting mitochondrial alterations could offer novel therapeutic avenues for PH.
- Further research into these metabolic changes may lead to improved treatments for PH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mitochondria
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

